Animal type melanoma: a report of a case with balloon-cell change and sentinel lymph node metastasis.

This study reports a case of a rare variant of melanoma, known as animal type melanoma, in a 27-year-old man. The research reveals important clues to the nature and progression of this type of cancer, displaying its ability to metastasize, which underpinned a subsequent treatment plan.

Explanation of the Research Paper

• The paper begins by explaining that animal type melanoma, named for its similarity to melanocytic neoplasms seen in gray horses and laboratory animals, is a rare variety of melanoma. Because of its infrequency, the full scope of its biological behavior is yet to be thoroughly understood.
• The study then details the specific case of a 27-year-old male patient diagnosed with animal type melanoma on his back. The melanoma exhibited areas of in situ changes (localized cancerous alteration), which disproved the possibility of it being metastatic melanoma (a melanoma that started from elsewhere).
• The melanoma was also characterized by a balloon-cell appareance in some regions and thick layers of heavily pigmented epithelioid melanocytes in others. These melanocytes infiltrated the entire dermis and extended into the dermal-subcutaneous interface, similar to a cellular blue nevus (a benign, usually heavily pigmented, lesion).
• The report notes that the melanocytic cells were not showing signs of maturation in the deeper areas of the lesion, indicating a persistently aggressive malignant growth. A separate nodule of pigmented epithelioid melanocytes, away from the main bulk of the lesion, suggested the possibility of a satellite lesion (additional lesion in the proximity of the original site).
• A lymphoscintigraphy (imaging of lymphatic flow) identified a sentinel lymph node (the first lymph node to receive lymphatic drainage from a tumor) in the patient’s right axilla (underarm). Subsequent axillary lymphadenectomy (removal of the lymph nodes in the underarm) revealed that the sentinel lymph node was dominated by metastatic melanoma, thus confirming the invasive nature of this form of melanoma.
• As a course of treatment, the patient was administered adjuvant chemotherapy with interferon alfa-2b to bolster the body’s immune response against the cancer cells. Four months post-treatment, the patient was reportedly in good condition, showing no signs of a recurrence or new metastases.